Market closedNon-fractional

Procaps Group/PROC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Procaps Group

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Ticker

PROC

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Luxembourg, Luxembourg

Employees

5,500

Procaps Group Metrics

BasicAdvanced
$282M
Market cap
4.87
P/E ratio
$0.51
EPS
-
Beta
-
Dividend rate
$282M
1.47
0.929
573.886
753.94
1.28%
6.28%
373.70%
4.875
0.614
6.4
-32.68
7.46
-4.80%
-12.90%

What the Analysts think about Procaps Group

Analyst Ratings

Majority rating from 2 analysts.
Buy

Procaps Group Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
6.84% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$118M
7.64%
Net income
$8.1M
-69.89%
Profit margin
6.84%
-72.02%

Procaps Group Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 60.00%
QuarterlyAnnual
Q4 22
Q1 23
Q3 23
Q4 23
Actual
$0.10
$0.07
$0.08
-
Expected
$0.01
-$0.04
$0.05
$0.09
Surprise
900.00%
-275.00%
60.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Procaps Group stock?

Procaps Group (PROC) has a market cap of $282M as of July 06, 2024.

What is the P/E ratio for Procaps Group stock?

The price to earnings (P/E) ratio for Procaps Group (PROC) stock is 4.87 as of July 06, 2024.

Does Procaps Group stock pay dividends?

No, Procaps Group (PROC) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Procaps Group dividend payment date?

Procaps Group (PROC) stock does not pay dividends to its shareholders.

What is the beta indicator for Procaps Group?

Procaps Group (PROC) does not currently have a Beta indicator.

Buy or sell Procaps Group stock

Buy or sell Procaps Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing